Sort by

Send to

Choose Destination

Links from PubMed

Items: 18


MicroRNA profiles in various hepatocellular carcinoma cell lines.

Morishita A, Iwama H, Fujihara S, Sakamoto T, Fujita K, Tani J, Miyoshi H, Yoneyama H, Himoto T, Masaki T.

Oncol Lett. 2016 Sep;12(3):1687-1692.


Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).

Reichl P, Mikulits W.

Oncol Rep. 2016 Aug;36(2):613-25. doi: 10.3892/or.2016.4842.


Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).

Byrnes KA, Phatak P, Mansour D, Xiao L, Zou T, Rao JN, Turner DJ, Wang JY, Donahue JM.

Oncotarget. 2016 Feb 23;7(8):8756-70. doi: 10.18632/oncotarget.6752.


miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.

Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J.

Oncotarget. 2015 Sep 15;6(27):24448-62.


The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.

Kinose Y, Sawada K, Nakamura K, Sawada I, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Takahashi K, Kurachi H, Lengyel E, Kimura T.

Oncotarget. 2015 May 10;6(13):11342-56.


miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion.

Yang C, Ning S, Li Z, Qin X, Xu W.

Cancer Cell Int. 2014 Dec 12;14(1):138. doi: 10.1186/s12935-014-0138-0.


The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis.

Fu W, Pang L, Chen Y, Yang L, Zhu J, Wei Y.

ScientificWorldJournal. 2014;2014:523979. doi: 10.1155/2014/523979.


A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.

Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X.

Cancer. 2014 Dec 1;120(23):3635-41. doi: 10.1002/cncr.28911.


MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.

Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, Kumar D.

PLoS One. 2013 Oct 22;8(10):e76994. doi: 10.1371/journal.pone.0076994.


Deciphering the unique microRNA signature in human esophageal adenocarcinoma.

Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, Belkhiri A, El-Rifai W.

PLoS One. 2013;8(5):e64463. doi: 10.1371/journal.pone.0064463.


GERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?

Illig R, Klieser E, Kiesslich T, Neureiter D.

Gastroenterol Res Pract. 2013;2013:643084. doi: 10.1155/2013/643084.


Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN.

Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632.


The role of microRNAs in cancers of the upper gastrointestinal tract.

Song S, Ajani JA.

Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):109-18. doi: 10.1038/nrgastro.2012.210. Review.


Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a.

Gu S, Chan WY.

Int J Mol Sci. 2012;13(7):8449-66. doi: 10.3390/ijms13078449. Review.


Regulation of Aerobic Glycolysis by microRNAs in Cancer.

Singh PK, Mehla K, Hollingsworth MA, Johnson KR.

Mol Cell Pharmacol. 2011;3(3):125-134.


MicroRNA profiling of diverse endothelial cell types.

McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK.

BMC Med Genomics. 2011 Nov 2;4:78. doi: 10.1186/1755-8794-4-78.


MicroRNA involvement in esophageal carcinogenesis.

David S, Meltzer SJ.

Curr Opin Pharmacol. 2011 Dec;11(6):612-6. doi: 10.1016/j.coph.2011.09.006. Review.

Items per page

Supplemental Content

Support Center